The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concordance of PD-L1 combined positive score (CPS) analysis between primary gastric cancer and matched peritoneal metastasis.
 
Valentina Massa
No Relationships to Disclose
 
Francesca Salani
No Relationships to Disclose
 
Giada Grelli
No Relationships to Disclose
 
Virginia Genovesi
No Relationships to Disclose
 
Caterina Vivaldi
Consulting or Advisory Role - AstraZeneca; Eisai/MSD; Roche; Taiho Oncology
Speakers' Bureau - BMS; SERVIER; TERUMO
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche
 
Francesca Signorini
No Relationships to Disclose
 
Clara Ugolini
No Relationships to Disclose
 
Maria Elena Filice
No Relationships to Disclose
 
Laura Bernardini
No Relationships to Disclose
 
Silvia Cesario
No Relationships to Disclose
 
Miriam Caccese
No Relationships to Disclose
 
Jessica Graziani
No Relationships to Disclose
 
Linda Bartalini
No Relationships to Disclose
 
Dario Berra
No Relationships to Disclose
 
Francesco Mangogna
No Relationships to Disclose
 
Vincenzo Nardini
No Relationships to Disclose
 
Gianluca Masi
Consulting or Advisory Role - AstraZeneca; Eisai; MSD Oncology; Roche; Roche
Research Funding - Terumo (Inst); Terumo (Inst)
Patents, Royalties, Other Intellectual Property - Terumo (Inst)
 
Lorenzo Fornaro
Honoraria - BMS GmbH & Co. KG; Incyte; Lilly; MSD; SERVIER
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/Daiichi Sankyo; Incyte; Lilly; MSD; SERVIER; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); BMS GmbH & Co. KG (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Incyte (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Nucana (Inst); Roche (Inst)